+关注
TenFace
暂无个人介绍
IP属地：上海
15
关注
0
粉丝
0
主题
0
勋章
主贴
热门
TenFace
2023-02-01
6
AnPac Bio-Medical Science Shares Rise 12% After Investment Agreements
TenFace
2022-10-29
666
AnPac Bio announces plan to implement ADS ratio change
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3460283921076064","uuid":"3460283921076064","gmtCreate":1497189900521,"gmtModify":1504149991828,"name":"TenFace","pinyin":"tenface","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/c5958f380d9ecdd022146bdfd7322181","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":15,"tweetSize":2,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"上海","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":622317351,"gmtCreate":1675214171173,"gmtModify":1675215382085,"author":{"id":"3460283921076064","authorId":"3460283921076064","name":"TenFace","avatar":"https://static.laohu8.com/c5958f380d9ecdd022146bdfd7322181","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3460283921076064","authorIdStr":"3460283921076064"},"themes":[],"htmlText":"6","listText":"6","text":"6","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/622317351","repostId":"2306489680","repostType":2,"repost":{"id":"2306489680","kind":"highlight","pubTimestamp":1674668340,"share":"https://www.laohu8.com/m/news/2306489680?lang=&edition=full","pubTime":"2023-01-26 01:39","market":"us","language":"en","title":"AnPac Bio-Medical Science Shares Rise 12% After Investment Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2306489680","media":"marketwatch","summary":"By Chris Wack AnPac Bio-Medical Science Co. Ltd. shares were up 12% to $8.15 after the company said ","content":"<html><body><div itemprop=\"articleBody\" role=\"document\"> <div> <div> <div aria-hidden=\"true\"></div> </div> </div> <p>By Chris Wack</p><pre></pre> <p>AnPac Bio-Medical Science Co. Ltd. shares were up 12% to $8.15 after the company said that in December and January, it signed definitive investment agreements with several third party investors.</p> <p>The company said investors agreed to buy 29.7 million newly issued Class A ordinary shares at 17.5 cents a share, for a total purchase price of $5.2 million.</p> <div> <p>The closing is expected to take place within 30 days after signing.</p> <p>Concurrently, for each Class A share purchased, the investors will receive two warrants, with each warrant to buy one Class A share at 21 cents a share. The warrants will be exercisable within two years from the date of issuance.</p> <p>AnPac Bio-Medical Science expects to use the proceeds for its business-to-business Asian food e-commerce and Asian food supply chain construction.</p><pre></pre> <p>Write to Chris Wack at chris.wack@wsj.com</p><pre></pre> </div> </div></body></html>","source":"mwatch_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AnPac Bio-Medical Science Shares Rise 12% After Investment Agreements</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnPac Bio-Medical Science Shares Rise 12% After Investment Agreements\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-01-26 01:39 GMT+8 <a href=https://www.marketwatch.com/story/anpac-bio-medical-science-shares-rise-12-after-investment-agreements-271674668375?mod=newsviewer_click><strong>marketwatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Chris Wack AnPac Bio-Medical Science Co. Ltd. shares were up 12% to $8.15 after the company said that in December and January, it signed definitive investment agreements with several third party ...</p>\n\n<a href=\"https://www.marketwatch.com/story/anpac-bio-medical-science-shares-rise-12-after-investment-agreements-271674668375?mod=newsviewer_click\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://images.barrons.com/im-709209?size=1.777777777777778&width=220 220w,https://images.barrons.com/im-709209?size=1.777777777777778&width=300 300w,https://images.barrons.com/im-709209?size=1.777777777777778&width=460 460w,https://images.barrons.com/im-709209?size=1.777777777777778&width=800 800w,https://images.barrons.com/im-709209?size=1.777777777777778&width=920 920w,https://images.barrons.com/im-709209?size=1.777777777777778&width=1240 1240w,https://images.barrons.com/im-709209?size=1.777777777777778&width=1240 1240w","relate_stocks":{"BK4139":"生物科技"},"source_url":"https://www.marketwatch.com/story/anpac-bio-medical-science-shares-rise-12-after-investment-agreements-271674668375?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2306489680","content_text":"By Chris Wack AnPac Bio-Medical Science Co. Ltd. shares were up 12% to $8.15 after the company said that in December and January, it signed definitive investment agreements with several third party investors. The company said investors agreed to buy 29.7 million newly issued Class A ordinary shares at 17.5 cents a share, for a total purchase price of $5.2 million. The closing is expected to take place within 30 days after signing. Concurrently, for each Class A share purchased, the investors will receive two warrants, with each warrant to buy one Class A share at 21 cents a share. The warrants will be exercisable within two years from the date of issuance. AnPac Bio-Medical Science expects to use the proceeds for its business-to-business Asian food e-commerce and Asian food supply chain construction. Write to Chris Wack at chris.wack@wsj.com","news_type":1},"isVote":1,"tweetType":1,"viewCount":10,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":665114119,"gmtCreate":1667031422731,"gmtModify":1667032961918,"author":{"id":"3460283921076064","authorId":"3460283921076064","name":"TenFace","avatar":"https://static.laohu8.com/c5958f380d9ecdd022146bdfd7322181","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3460283921076064","authorIdStr":"3460283921076064"},"themes":[],"htmlText":"666","listText":"666","text":"666","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/665114119","repostId":"2276419351","repostType":2,"repost":{"id":"2276419351","kind":"highlight","pubTimestamp":1666093817,"share":"https://www.laohu8.com/m/news/2276419351?lang=&edition=full","pubTime":"2022-10-18 19:50","market":"us","language":"en","title":"AnPac Bio announces plan to implement ADS ratio change","url":"https://stock-news.laohu8.com/highlight/detail?id=2276419351","media":"seekingalpha","summary":"AnPac Bio (NASDAQ:ANPC) plans to change the ratio of the company’s American Depositary Shares to its","content":"<html><body><ul>\n<li>AnPac Bio (<span>NASDAQ:ANPC</span>) plans to change the ratio of the company’s American Depositary Shares to its Class A ordinary shares from one ADS representing one Class A ordinary share to one ADS representing twenty Class A ordinary shares.</li>\n<li>The change in the ADS ratio is expected to take place on November 4, 2022.</li>\n<li>For the company’s ADS holders, the change in the ADS ratio will have the same effect as a one-for-twenty reverse ADS split. </li>\n<li>The ADSs will continue to be traded on Nasdaq under the symbol “ANPC.”</li>\n<li>There will be no change to the company’s Class A ordinary shares.</li>\n<li>Shares are <font color=\"green\">up 1.7%</font> premarket.</li>\n</ul></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AnPac Bio announces plan to implement ADS ratio change</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnPac Bio announces plan to implement ADS ratio change\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-18 19:50 GMT+8 <a href=https://seekingalpha.com/news/3892141-anpac-bio-announces-plan-to-implement-ads-ratio-change><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AnPac Bio (NASDAQ:ANPC) plans to change the ratio of the company’s American Depositary Shares to its Class A ordinary shares from one ADS representing one Class A ordinary share to one ADS ...</p>\n\n<a href=\"https://seekingalpha.com/news/3892141-anpac-bio-announces-plan-to-implement-ads-ratio-change\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QID":"纳指两倍做空ETF","QQQ":"纳指100ETF","SQQQ":"纳指三倍做空ETF",".IXIC":"NASDAQ Composite","QLD":"纳指两倍做多ETF","TQQQ":"纳指三倍做多ETF","PSQ":"纳指反向ETF","BK4139":"生物科技"},"source_url":"https://seekingalpha.com/news/3892141-anpac-bio-announces-plan-to-implement-ads-ratio-change","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2276419351","content_text":"AnPac Bio (NASDAQ:ANPC) plans to change the ratio of the company’s American Depositary Shares to its Class A ordinary shares from one ADS representing one Class A ordinary share to one ADS representing twenty Class A ordinary shares.\nThe change in the ADS ratio is expected to take place on November 4, 2022.\nFor the company’s ADS holders, the change in the ADS ratio will have the same effect as a one-for-twenty reverse ADS split. \nThe ADSs will continue to be traded on Nasdaq under the symbol “ANPC.”\nThere will be no change to the company’s Class A ordinary shares.\nShares are up 1.7% premarket.","news_type":1},"isVote":1,"tweetType":1,"viewCount":125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":622317351,"gmtCreate":1675214171173,"gmtModify":1675215382085,"author":{"id":"3460283921076064","authorId":"3460283921076064","name":"TenFace","avatar":"https://static.laohu8.com/c5958f380d9ecdd022146bdfd7322181","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3460283921076064","authorIdStr":"3460283921076064"},"themes":[],"htmlText":"6","listText":"6","text":"6","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/622317351","repostId":"2306489680","repostType":2,"isVote":1,"tweetType":1,"viewCount":10,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":665114119,"gmtCreate":1667031422731,"gmtModify":1667032961918,"author":{"id":"3460283921076064","authorId":"3460283921076064","name":"TenFace","avatar":"https://static.laohu8.com/c5958f380d9ecdd022146bdfd7322181","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3460283921076064","authorIdStr":"3460283921076064"},"themes":[],"htmlText":"666","listText":"666","text":"666","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/665114119","repostId":"2276419351","repostType":2,"isVote":1,"tweetType":1,"viewCount":125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
